Daptomycin and its immunomodulatory effect: Consequences for antibiotic treatment of methicillin-resistant Staphylococcus aureus wound infections after heart surgery

Frontiers in Immunology

Volumn 5, Issue MAR, 2014, Pages

  Tirilomis, Theodor ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

Antibiotic treatment; Cardiac surgery; Mediastinitis; Resistant bacteria; Staphylococcus aureus; Wound debridement

Indexed keywords

ALPHA TOCOPHEROL; CLINDAMYCIN; CYTOKINE; DAPTOMYCIN; LINEZOLID; TIGECYCLINE; VANCOMYCIN;

ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; CYTOKINE PRODUCTION; DRUG EFFICACY; HEART SURGERY; HUMAN; IMMUNE RESPONSE; IMMUNOMODULATION; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MULTICENTER STUDY (TOPIC); POSTOPERATIVE INFECTION; PROTEIN EXPRESSION; SHORT SURVEY; SURGICAL INFECTION;

EID: 84897934450     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2014.00097     Document Type: Short Survey

References (47)

1. Fluit AC, Wielders CL, Verhoef J, Schmitz FJ. Epidemiology and susceptibility of 3,051 Staphylococcus aureus isolates from 25 university hospitals participating in the European SENTRY study. J Clin Microbiol (2001) 39:3727-32. doi:10.1128/JCM.39.10.3727-3732.2001
2. Layer F, Werner G. Eigenschaften, Häufigkeit und Verbreitung von MRSA in Deutschland-Update 2011/2012. In: Robert Koch-Institut, editor. Epidemiologisches Bulletin. Berlin: Robert Koch-Institut (2013). p. 187-93.
3. Zangrillo A, Landoni G, Fumagalli L, Bove T, Bellotti F, Sottocorna O, et al. Methicillin-resistant Staphylococcus species in a cardiac surgical intensive care unit: a 5-year experience. J Cardiothorac Vasc Anesth (2006) 20:31-7. doi:10.1053/j.jvca.2004.12.002
4. Hortal J, Muñoz P, Cuerpo G, Litvan H, Rosseel PM, Bouza E. Ventilator-associated pneumonia in patients undergoing major heart surgery: an incidence study in Europe. Crit Care (2009) 13:R80. doi:10.1186/cc7896
5. Lola I, Levidiotou S, Petrou A, Arnaoutoglou H, Apostolakis E, Papadopoulos GS. Are there independent predisposing factors for postoperative infections following open heart surgery? J Cardiothorac Surg (2011) 6:151. doi:10.1186/1749-8090-6-151
6. Andreasen JJ, Dethlefsen C, Modrau IS, Baech J, Schonheyder HC, Moeller JK, et al. Storage time of allogeneic red blood cells is associated with risk of severe postoperative infection after coronary artery bypass grafting. Eur J Cardiothorac Surg (2011) 39:329-34. doi:10.1016/j.ejcts.2010.06.019
7. Ryan T, Mc Carthy JF, Rady MY, Serkey J, Gordon S, Starr NJ, et al. Early bloodstream infection after cardiopulmonary bypass: frequency rate, risk factors, and implications. Crit Care Med (1997) 25:2009-14. doi:10.1097/00003246-199712000-00018
8. Hamers LA, Linssen CF, Lancé MD, Maessen JG, Weerwind P, Winkens B, et al. Positive cultures from cardiopulmonary bypass: prevalence and relevance regarding postoperative infection. Eur J Cardiothorac Surg (2011) 40:372-8. doi:10.1016/j.ejcts.2010.11.063
9. El Oakley RM, Wright JE. Postoperative mediastinitis: classification and management. Ann Thorac Surg (1996) 61:1030-6. doi:10.1016/0003-4975(95)01035-1
10. Gummert JF, Barten MJ, Hans C, Kluge M, Doll N, Walther T, et al. Mediastinitis and cardiac surgery-an updated risk factor analysis in 10,373 consecutive adult patients. Thorac Cardiovasc Surg (2002) 50:87-91. doi:10.1055/s-2002-26691
11. Kubota H, Miyata H, Motomura N, Ono M, Takamoto S, Harii K, et al. Deep sternal wounds infection after cardiac surgery. J Cardiothorac Surg (2013) 8:132. doi:10.1186/1749-8090-8-132
12. Gårdlund B, Bitkover CY, Vaage J. Postoperative mediastinitis in cardiac surgery-microbiology and pathogenesis. Eur J Cardiothorac Surg (2002) 21:825-30. doi:10.1016/S1010-7940(02)00084-2
13. Cobo J, Aguado JM, Cortina J, Cobo P, Martin del Hierro JL, Rufilanchas JJ, et al. Infection of sternal wound in heart surgery: analysis of 1000 operations. Med Clin (Barc) (1996) 106:401-4.
14. Mekontso-Dessap A, Kirsch M, Brun-Buisson C, Loisance D. Poststernotomy mediastinitis due to Staphylococcus aureus: comparison of methicillin-resistant and methicillin susceptible Cases. Clin Infect Dis (2001) 32:877-83. doi:10.1086/319355
15. Mastoraki A, Kriaras I, Douka E, Mastoraki S, Stravopodis G, Geroulanos S. Methicillin-resistant Staphylococcus aureus preventing strategy in cardiac surgery. Interact Cardiovasc Thorac Surg (2008) 7:452-6. doi:10.1510/icvts.2008.176156
16. Colombier S, Kessler U, Ferrari E, von Segesser LK, Berdajs DA. Influence of deep sternal wound infection on long-term survival after cardiac surgery. Med Sci Monit (2013) 19:668-73. doi:10.12659/MSM.889191
17. Cafferkey MT, Luke DA, Keane CT. Sternal and costochondral infections with gentamicin and methicillin resistant Staphylococcus aureus following thoracic surgery. Scand J Infect Dis (1983) 15:267-70.
18. Carrier M, Marchand R, Auger P, Hébert Y, Pellerin M, Perrault LP, et al. Methicillin-resistant Staphylococcus aureus infection in a cardiac surgical unit. J Thorac Cardiovasc Surg (2002) 123:40-4. doi:10.1067/mtc.2002.118505
19. Miller LG, McKinnell JA, Vollmer ME, Spellberg B. Impact of methicillin-resistant Staphylococcus aureus prevalence among S. aureus isolates on surgical site infection risk after coronary artery bypass surgery. Infect Control Hosp Epidemiol (2011) 32:342-50. doi:10.1086/658668
20. Walsh EE, Greene L, Kirshner R. Sustained reduction in methicillin-resistant Staphylococcus aureus wound infections after cardiothoracic surgery. Arch Intern Med (2011) 171:68-73. doi:10.1001/archinternmed.2010.326
21. Bull AL, Worth LJ, Richards MJ. Impact of vancomycin surgical antibiotic prophylaxis on the development of methicillin-sensitive Staphylococcus aureus surgical site infections: report from Australian Surveillance Data (VICNISS). Ann Surg (2012) 256:1089-92. doi:10.1097/SLA.0b013e31825fa398
22. Geisel R, Schmitz FJ, Thomas L, Berns G, Zetsche O, Ulrich B, et al. Emergence of heterogeneous intermediate vancomycin resistance in Staphylococcus aureus isolates in the Düsseldorf area. J Antimicrob Chemother (1999) 43:846-8. doi:10.1093/jac/43.6.846
23. Stevens DL, Herr D, Lampiris H, Hunt JL, Batts DH, Hafkin B, et al. Study Group. Linezolid versus vancomycin for the treatment of methicillin-resistant Staphylococcus aureus infections. Clin Infect Dis (2002) 34:1481-90. doi:10.1086/340353
24. Itani KM, Dryden MS, Bhattacharyya H, Kunkel MJ, Baruch AM, Weigelt JA. Efficacy and safety of linezolid versus vancomycin for the treatment of complicated skin and soft-tissue infections proven to be caused by methicillin-resistant Staphylococcus aureus. Am J Surg (2010) 199:804-16. doi:10.1016/j.amjsurg.2009.08.045
25. Bounthavong M, Hsu DI. Efficacy and safety of linezolid in methicillin-resistant Staphylococcus aureus (MRSA) complicated skin and soft tissue infection (cSSTI): a meta-analysis. Curr Med Res Opin (2010) 26:407-21. doi:10.1185/03007990903454912
26. Stein GE, Wells EM. The importance of tissue penetration in achieving successful antimicrobial treatment of nosocomial pneumonia and complicated skin and soft-tissue infections caused by methicillin-resistant Staphylococcus aureus: vancomycin and linezolid. Curr Med Res Opin (2010) 26:571-88. doi:10.1185/03007990903512057
27. Seaton RA. Daptomycin: rationale and role in the management of skin and soft tissue infections. J Antimicrob Chemother (2008) 62(Suppl 3):iii15-23. doi:10.1093/jac/dkn368
28. Kim A, Suecof LA, Sutherland CA, Gao L, Kuti JL, Nicolau DP. In vivo microdialysis study of the penetration of daptomycin into soft tissues in diabetic versus healthy volunteers. Antimicrob Agents Chemother (2008) 52:3941-6. doi:10.1128/AAC.00589-08
29. Kephart PA, Esposito AL. Comparison of the investigational drug, LY146032, with vancomycin in experimental pneumonia due to methicillin-resistant Staphylococcus aureus. J Antimicrob Chemother (1988) 21:33-9. doi:10.1093/jac/21.1.33
30. Fletcher L. Cubist highlights FDA's antiobiotic resistance. Nat Biotechnol (2002) 20:206-7. doi:10.1038/nbt0302-206
31. Schriever CA, Fernández C, Rodvold KA, Danziger LH. Daptomycin: a novel cyclic lipopeptide antimicrobial. Am J Health Syst Pharm (2005) 62:1145-58.
32. Popov AF, Schmitto JD, Tirilomis T, Bireta C, Coskun KO, Mokashi SA, et al. Daptomycin as a possible new treatment option for surgical management of methicillin-resistant Staphylococcus aureus sternal wound infection after cardiac surgery. J Cardiothorac Surg (2010) 5:57. doi:10.1186/1749-8090-5-57
33. Sakoulas G, Brown J, Lamp KC, Friedrich LV, Lindfield KC. Clinical outcomes of patients receiving daptomycin for the treatment of Staphylococcus aureus infections and assessment of clinical factors for daptomycin failure: a retrospective cohort study utilizing the Cubicin Outcomes Registry and Experience. Clin Ther (2009) 31:1936-45. doi:10.1016/j.clinthera.2009.09.012
34. Chamberlain RS, Culshaw DL, Donovan BJ, Lamp KC. Daptomycin for the treatment of surgical site infections. Surgery (2009) 146:316-24. doi:10.1016/j.surg.2009.03.037
35. Kullar R, Casapao AM, Davis SL, Levine DP, Zhao JJ, Crank CW, et al. A multicentre evaluation of the effectiveness and safety of high-dose daptomycin for the treatment of infective endocarditis. J Antimicrob Chem (2013) 68:2921-6. doi:10.1093/jac/dkt294
36. Kullar R, Davis SL, Levine DP, Zhao JJ, Crank CW, Segreti J, et al. High-dose daptomycin for treatment of complicated Gram-positive infections: a large, multicenter, retrospective study. Pharmacotherapy (2011) 31:527-36. doi:10.1592/phco.31.6.527
37. Silverman JA, Perlmutter NG, Shapiro HM. Correlation of daptomycin bactericidal activity and membrane depolarization in Staphylococcus aureus. Antimicrob Agents Chemother (2003) 47:2538-44. doi:10.1128/AAC.47.8.2538-2544.2003
38. Pogliano J, Pogliano N, Silverman JA. Daptomycin-mediated reorganization of membrane architecture causes mislocalization of essential cell division proteins. J Bacteriol (2012) 194:4494-504. doi:10.1128/JB.00011-12
39. Berti AD, Sakoulas G, Nizet V, Tewhey R, Rose WE. Beta-lactam antibiotics targeting PBP1 selectively enhance daptomycin activity against methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother (2013) 57:5005-12. doi:10.1128/AAC.00594-13
40. Raad I, Hanna H, Jiang Y, Dvorak T, Reitzel R, Chaiban G, et al. Comparative activities of daptomycin, linezolid, and tigecycline against catheter-related methicillin-resistant Staphylococcus bacteremic isolates embedded in biofilm. Antimicrob Agents Chemother (2007) 51:1656-60. doi:10.1128/AAC.00350-06
41. Kaplan JB. Antiobiotic-induced biofilm formation. Int J Artif Organs (2011) 34:737-51. doi:10.5301/ijao.5000027
42. Dosler S, Mataraci E. In vitro pharmacokinetics of antimicrobial cationic peptides alone and in combination with antibiotics against methicillin resistant Staphylococcus aureus biofilms. Peptides (2013) 49:53-8. doi:10.1016/j.peptides.2013.08.008
43. Pichereau S, Moran JJM, Hayney MS, Shukla SK, Sakoulas G, Rose WE. Concentration-dependent effects of antimicrobials on Staphylococcus aureus toxin-mediated cytokine production from peripheral blood mononuclear cells. J Antimicrob Chemother (2012) 67:123-9. doi:10.1093/jac/dkr417
44. Thallinger C, Rothenburger M, Marsik C, Wuenscher S, Popovic M, Endler G, et al. Daptomycin does not exert immunomodulatory effects in an experimental endotoxin model of human whole blood. Pharmacology (2008) 81:57-62. doi:10.1159/000108106
45. Salinthone S, Kerns AR, Tsang V, Carr DW. a-Tocopherol (vitamin E) stimulates cyclic AMP production in human peripheral mononuclear cells and alters immune function. Mol Immunol (2013) 53:173-8. doi:10.1016/j.molimm.2012.08.005
46. Provinciali M, Cirioni O, Orlando F, Pierpaoli E, Barucca A, Silvestri C, et al. Vitamin E improves the in vivo efficacy of tigecycline and daptomycin in an animal model of wounds infected with meticillin-resistant Staphylococcus aureus. J Med Microbiol (2011) 60:1806-12. doi:10.1099/jmm.0.032516-0
47. Pierpaoli E, Cirioni O, Barucca A, Orlando F, Silvestri C, Giacometti A, et al. Vitamin E supplementation in old mice induces antimicrobial activity and improves the efficacy of daptomycin in an animal model of wounds infected with methicillin-resistant Staphylococcus aureus. J Antimicrob Chemother (2011) 66:2184-5. doi:10.1093/jac/dkr254